Sort
40,608 grants matching “prostate cancer”
Urologic Epithelial Stem Cells
$400,000University Of Washington · U01 · FY2004 · DK
9.4TESLA/310MM MR IMAGING AND SPECTROSCOPY SYSTEM: HEI: PROSTATE CANCER
$400,000Northshore Univ Healthsystem Res Inst · S10 · FY2004 · RR
Beta Camera and Laparoscopic Probe for Surgical Cancer Removal.
$400,000Farhad Daghighian · Intra Medical Imaging, Llc · R44 · FY2009 · CA
Collaborative Research: Heterogeneous Cancer Cell Mechanics Differentially Drives Mechanosensing and Migration
$400,000Adam J Engler · University Of California-San Diego · · FY2018 · ENG
Developing a Novel Biologic Therapy to Eradicate Brain Cancer and Brain Metastasis
$400,000Donald Davidson · Creative Biotherapeutics, Llc · R43 · FY2024 · CA
Novel small-molecule therapeutics for malignant peripheral nerve sheath tumor
$400,000Tsung-Chieh Shih · Kibio Inc. · R43 · FY2022 · CA
Development of a radiation-activatable nanoparticle for lung cancer therapy
$400,000Zhi Liu · Athna Biotech, Inc. · R41 · FY2021 · CA
PLK1 and EGFR targeted nanoconstruct as a monotherapy and a radiation sensitizer for lung cancer
$400,000Worapol Ngamcherdtrakul · Pdx Pharmaceuticals, Inc. · R44 · FY2023 · CA
Washington University Molecular Imaging Center
$400,000Washington University · P50 · FY2002 · CA
MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER
$400,000Sloan-Kettering Institute For Cancer Res · P50 · FY2002 · CA
Development of a novel, RNA-interference-based therapeutic to treat prostate cancer
$400,000Robert Schickel · Nuago Therapeutics Inc · R41 · FY2024 · CA
MOLECULAR IMAGING CENTER PLANNING GRANT
$400,000Duke University · P20 · FY2002 · CA
Small Molecule N-myc Degraders as Novel Cancer Therapeutic Agents
$399,999Dennis Liang Fei · Stemsynergy Therapeutics, Inc. · R43 · FY2022 · CA
FY20 SBIR PHASE I TOPIC #400 - AMBAY RADI-SENSE: NON-INVASIVE, NOVEL TEST TO MONITOR BIOLOGICAL RESPONSE TO RADIOTHERAPY
$399,997Meena Chandok · Ambay Immune Sensors And Controls, Llc · N43 · FY2020 · CA
UNIVERSITY OF MARYLAND GREENEBAUM CANCER CENTER SUPPORT GRANT
$399,995Kevin J Cullen · University Of Maryland Baltimore · P30 · FY2020 · CA
Transforming prostate cancer diagnosis: Feasibility testing of a novel system for integrated endorectal MRI and in-bore biopsy
$399,995Robert Duffy Dufresne · Omnecoil Instruments, Inc. · R41 · FY2025 · CA
PROSTATE AND BREAST CANCER, THE MOST COMMON CANCER IN MEN AND WOMEN IN THE USA, ARE NOT ONLY LINKED BY COMMON HORMONAL BIOSYNTHETIC PATHWAYS BUT ARE
$399,985Georgetown University · · FY2014 · National Aeronautics and Space Administration
Understanding the full spectrum of epigenetic vulnerability in cancer through the delineation of DNA methylation function in gene 3' end
$399,981Angela H Ting · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · CA
The Development of Radiolabeled PSMA Agent with Low Salivary Gland Uptake
$399,981Zhanhong Wu · Tripill Biotechnology, Corp. · R41 · FY2024 · CA
Targeted prostate biopsy using mathematical optimization
$399,975Christos Davatzikos · University Of Pennsylvania · R01 · FY2007 · CA
Integrative molecular imaging and sequencing of prostate cancer
$399,969Arul M Chinnaiyan · University Of Michigan At Ann Arbor · U01 · FY2016 · CA
Epithelial-Mesenchymal Transition Signature Markers (EMTsm) with Machine Learning-Based Analysis as a Predictor of Metastatic Prostate Cancer
$399,954Harvey D Homan · Metastx Llc · R43 · FY2025 · CA
TOPIC 455: A LOW COST, POINT-OF-CARE DETECTION DEVICE FOR PROSTATE SPECIFIC ANTIGEN USING A PAPER-BASED FLOW ASSAY
$399,925Takako Takeda · Triton Systems, Inc. · N43 · FY2024 · CA
An off-the-shelf tumor cell vaccine with HLA-matching alleles for the personalized treatment of advanced solid tumors
$399,918William Valentine Williams · Briacell Therapeutics Corp · R43 · FY2023 · CA
Project 3: Targeting SK2/S1P Signaling for the Regulation of c-Myc and Tumor Suppression
$399,911Carolyn D Britten · Medical University Of South Carolina · P01 · FY2021 · CA